This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: The Innovations of Eugene Falk
Introduction
Eugene Falk is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can be used as medicaments.
Latest Patents
Eugene Falk holds a patent for "Substituted phenylalkenoylguanidines, process for their preparation, and - Substituted phenylalkenoylguanidines, processes for their preparation, uses as medicaments or diagnostics, and medicaments containing them." This invention relates to substituted phenylalkenoylguanidines and their pharmaceutically tolerable salts and physiologically functional derivatives. The compounds are particularly suitable for the prophylaxis or treatment of gallstones.
Career Highlights
Eugene Falk is associated with Aventis Pharma Deutschland GmbH, where he has been instrumental in advancing pharmaceutical research and development. His work has led to innovative solutions in the treatment of various medical conditions.
Collaborations
Eugene has collaborated with notable colleagues such as Andreas Gerhard Weichert and Alfons Enhsen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Eugene Falk's contributions to the field of pharmaceuticals through his patent and work at Aventis Pharma highlight his role as a significant inventor in the industry. His innovations continue to impact the medical field positively.